(Q30405451)

English

Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

0 references

1 reference

based on heuristic

inferred from title

Theresia Popow-Kraupp

9

object named as

Theresia Popow-Kraupp

0 references

Guido A Gualdoni

object named as

Guido A Gualdoni

4

0 references

Monika Redlberger-Fritz

object named as

Monika Redlberger-Fritz

8

0 references

object named as

Heimo Lagler

1

0 references

object named as

Heinz Burgmann

10

0 references

author name string

Judith M Wenisch

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Selma Tobudic

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Susanne Rödler

5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Susanne Rasoul-Rockenschaub

6

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Peter Jaksch

7

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Theresia Popow-Kraupp

9

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

0 references

publication date

29 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

6888-6893

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Pandemic influenza A/H1N1 virus infection in solid organ transplant recipients: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

Guidance on novel influenza A/H1N1 in solid organ transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

The 2009 A (H1N1) influenza virus pandemic: A review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

Influenza control in the 21st century: Optimizing protection of older adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

The humoral response to live and inactivated influenza vaccines administered alone and in combination to young adults and elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

Influenza vaccination in elderly people

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

Immunogenicity and efficacy in hemodialysis patients of an AS03(A)-adjuvanted vaccine for 2009 pandemic influenza A(H1N1): a nonrandomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

The effect of age and natural priming on the IgG and IgA subclass responses after parenteral influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

Influenza vaccination is efficacious and safe in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.050

7 January 2021

Identifiers

10.1016/J.VACCINE.2011.07.050

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30405451&oldid=1610249177"